CEP Magazine
Should Highly Regulated Public Companies Have Board-Level Compliance Committees?
November 2021
In this CEP Magazine article, Sidley partners Holly J. Gregory and Paul E. Kalb, MD, the co-chair of Sidley’s Executive Compensation and Corporate Governance practice and the global head of Sidley’s Healthcare and FDA Group, respectively, discuss the considerations evaluating whether highly regulated public companies should have board-level compliance committees.
Copyright 2021 CEP Magazine, a publication of the Society of Corporate Compliance and Ethics (SCCE).
Offices
Capabilities
Suggested News & Insights
Court of Chancery Confirms No Price-Maximization Duty on Public Benefit Corporation DirectorsSeptember 8, 2026Strayed from the Path: Dodiya v. Franklin and the Emerging Rules of the DGCL’s Section 144 Safe HarborsSeptember 4, 2026Sidley “Highly Recommended” in Latin Lawyer 250 2027August 31, 2026Heightened Means Heightened: Chancery’s First Read of SB 21’s New Presumption Shuts Down Demand FutilityAugust 26, 2026Mind the Gap: Delaware Court of Chancery’s Clarification of the Implied Covenant’s Contractual Gap-Filling RoleAugust 18, 2026What to Expect in SEC Rulemaking: Takeaways From the SEC’s Spring 2026 Regulatory AgendaAugust 18, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory